{"id":"oxyphencyclimine","rwe":[],"tags":[{"label":"oxyphencyclimine","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Muscarinic acetylcholine receptor M1","category":"target"},{"label":"CHRM1","category":"gene"},{"label":"CHRM3","category":"gene"},{"label":"A03AA01","category":"atc"},{"label":"Off-Patent","category":"patent"},{"label":"Active","category":"status"},{"label":"Peptic ulcer","category":"indication"}],"phase":"marketed","safety":{"contraindications":["Alcoholism","Anemia","Breastfeeding (mother)","Depressive disorder","Disease of liver","Dyspnea","Hepatic coma","Hepatic encephalopathy","Hepatic failure","Hyperammonemia","Neutropenic disorder","Poisoning by phenobarbital","Porphyria","Pregnancy, function","Sleep apnea","Substance abuse","Suicidal thoughts","Thrombocytopenic disorder"]},"trials":[],"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=OXYPHENCYCLIMINE","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T03:33:39.215874+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T03:33:44.284250+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=OXYPHENCYCLIMINE","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T03:33:44.576426+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Muscarinic acetylcholine receptor M1 antagonist","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T03:33:45.619916+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200891/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T03:33:45.281946+00:00"}},"allNames":"daricon","offLabel":[],"synonyms":["oxyphencyclimine monohydrochloride","daricon","oxyphencyclimine hydrochloride","oxyphencyclimine","oxyphencyclimine HCl"],"timeline":[],"aiSummary":"Daricon (Oxyphencyclimine) is a small molecule drug that targets the muscarinic acetylcholine receptor M1. It is classified as an oxyphencyclimine and is used to treat peptic ulcers. As an off-patent medication, Daricon is no longer protected by active patents, making it available as a generic option. However, there are currently no generic manufacturers listed. This medication's commercial status and availability may vary depending on the region and market.","approvals":[{"date":"","orphan":false,"company":"","regulator":"FDA"}],"brandName":"Daricon","ecosystem":[{"indication":"Peptic ulcer","otherDrugs":[{"name":"algeldrate","slug":"algeldrate","company":"Sanofi Aventis Us"},{"name":"almasilate","slug":"almasilate","company":""},{"name":"chlordiazepoxide","slug":"chlordiazepoxide","company":"Valeant Pharm Intl"},{"name":"dexlansoprazole","slug":"dexlansoprazole","company":"Takeda Pharms Usa"}],"globalPrevalence":64000000}],"mechanism":{"target":"Muscarinic acetylcholine receptor M1","novelty":"First-in-class","targets":[{"gene":"CHRM1","source":"DrugCentral","target":"Muscarinic acetylcholine receptor M1","protein":"Muscarinic acetylcholine receptor M1"},{"gene":"CHRM3","source":"DrugCentral","target":"Muscarinic acetylcholine receptor M3","protein":"Muscarinic acetylcholine receptor M3"}],"modality":"Small Molecule","drugClass":"oxyphencyclimine","explanation":"","oneSentence":"","technicalDetail":"Oxyphencyclimine acts as a competitive antagonist at the muscarinic acetylcholine receptor M1, inhibiting the parasympathetic stimulation of gastric acid secretion."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/2026","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=OXYPHENCYCLIMINE","fields":["publications"],"source":"PubMed/NCBI"},{"id":3,"url":"https://www.fda.gov/drugs/drug-approvals-and-databases/orange-book-data-files","fields":["patents","exclusivity","genericManufacturers"],"source":"FDA Orange Book"}],"_enrichedAt":"2026-03-30T15:11:56.303306","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T03:33:46.858287+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"dicycloverine","drugSlug":"dicycloverine","fdaApproval":"1950-05-11","relationship":"same-class"}],"genericName":"oxyphencyclimine","indications":{"approved":[{"name":"Peptic ulcer","source":"DrugCentral","snomedId":13200003,"regulator":"FDA","usPrevalence":null,"globalPrevalence":64000000,"prevalenceMethod":"curated","prevalenceSource":"Aliment Pharmacol Ther, 2009 (PMID:19220208)"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"patentStatus":"Off-patent — no active Orange Book patents","relatedDrugs":[{"drugId":"dicycloverine","brandName":"dicycloverine","genericName":"dicycloverine","approvalYear":"1950","relationship":"same-class"}],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"_patentsChecked":true,"crossReferences":{"NUI":"N0000146724","MMSL":"NOCODE","NDDF":"001754","UNII":"4V44H1O8XI","VUID":"4018397","CHEBI":"CHEBI:7868","VANDF":"4018397","INN_ID":"839","RXNORM":"32698","UMLSCUI":"C0069833","chemblId":"CHEMBL1200891","ChEMBL_ID":"CHEMBL1495","KEGG_DRUG":"D01006","DRUGBANK_ID":"DB00383","PUBCHEM_CID":"4642","SNOMEDCT_US":"27499006","IUPHAR_LIGAND_ID":"7256","SECONDARY_CAS_RN":"125-52-0","MESH_SUPPLEMENTAL_RECORD_UI":"C100201"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":37,"therapeuticAreas":["Other"],"atcClassification":{"source":"DrugCentral","atcCode":"A03AA01","allCodes":["A03AA01","A03CA03"]},"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturers":0,"_genericFilersChecked":true,"genericManufacturerList":[],"status":"approved","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"1982","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T03:33:46.858287+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":false,"score":1}}